Skip to main content
Meet Ebglyss
gettingstarted

To learn about potential savings, enroll with Lilly Support Services for EBGLYSS (lebrikizumab-lbkz).

Check out this video to learn more about getting started with EBGLYSS

About the device 

A device designed with you in mind

In two studies, 94% of adults agreed the Pen was easy to use and were confident in their ability to use it.

*Results from two studies using a similar approved Pen with the same use steps.

EBGLYSS gives you the flexibility to choose the device option that best suits your needs

device

The singe-dose Prefilled Pen offers:

  • At-home administration

  • Hidden needle and automated injection

  • Up to 15 second injection time

  • Confirmation that you administered completely

    • You'll hear 2 clicks, one when you start the injection, and one at the end to tell you that the injection is complete

    • The injection is complete when the gray plunger is visible

A single dose of Ebglyss

The single-dose Prefilled Syringe offers: 

  • At-home administration

  • Ability to control speed of injection

SELECT IMPORTANT SAFETY INFORMATION

Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.

Injection Training through Lilly Support Services

Lilly Support Services for EBGLYSS provides additional support to help you feel more prepared using your EBGLYSS device. Access resources like videos which you can view at any time and receive personalized training with a registered nurse.

For important administration and preparation instructions, talk to your doctor and refer to the Instructions for Use that came with your device.

Injection Training Videos

First time using your EBGLYSS device? Watch the injection training video below for guidance and best practices when using your EBGLYSS device.

Prefilled Pen Injection Training Video

Prefilled Syringe Injection Training Video

SELECT IMPORTANT SAFETY INFORMATION

Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:

  • Have a parasitic (helminth) infection.

  • Are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with EBGLYSS.

  • Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy.

  • Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk.

  • Take prescription or over-the-counter medicines, vitamins, and herbal supplements.

Let's get started

dosing_timeline

The recommended dosage of EBGLYSS is:

  • An initial dose of 500 mg (two 250-mg injections) at week 0 and week 2, followed by

  • 250 mg every 2 weeks until week 16 or later, when adequate clinical response is achieved

  • Maintenance dose is 250 mg every 4 weeks

Discover once-monthly dosing with EBGLYSS

After 4 months of taking EBGLYSS every 2 weeks, you and your doctor
can discuss switching to once-monthly dosing.

Sharps Disposal Container

To receive your free sharps disposal container, select “Sharps Disposal Container” during the Lilly Support Services for EBGLYSS enrollment process.

Dispose of used Pen properly

Put the used EBGLYSS Pen in an FDA-cleared sharps disposal container right away after use.
Do not throw away EBGLYSS Pen(s) in your household trash. 
Do not recycle your used sharps disposal container. 
Keep sharps container away from children and pets. 
When your sharps container is almost full, follow your community guidelines for the right way to dispose of the sharps container.
For more information about safe sharps disposal, and for specific information about sharps disposal in the state you live in, go to the FDA website at: http://www.fda.gov/safesharpsdisposal

Dispose of used Syringe properly

Put the used EBGLYSS Syringe in an FDA-cleared sharps disposal container right away after use. 
Do not throw away EBGLYSS Syringe(s) in your household trash. 
Do not recycle your used sharps disposal container.
Keep sharps container away from children and pets. 
When your sharps container is almost full, follow your community guidelines for the right way to dispose of the sharps container.
For more information about safe sharps disposal, and for specific information about sharps disposal in the state you live in, go to the FDA website at: http://www.fda.gov/safesharpsdisposal

Please see the Instructions for Use included with the EBGLYSS device.

To have a new sharps disposal container sent to you, call Lilly Support Services at 
1-800-LillyRx (1-800-545-5979) from Monday to Friday between 8 am and 10 pm ET.

Now that you've taken EBGLYSS, learn how your body might respond.

SAFETY SUMMARY

Warnings - Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.

Before using
Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:

  • Have a parasitic (helminth) infection.

  • Are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with EBGLYSS.

  • Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy.

  • Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Possible side effects
EBGLYSS can cause serious side effects, including:

  • Allergic reactions. EBGLYSS can cause allergic reactions that may sometimes be severe. Stop using EBGLYSS and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms:

    • breathing problems or wheezing

    • swelling of the face, lips, mouth, tongue or throat

    • hives

    • itching

    • fainting, dizziness, feeling lightheaded

    • skin rash

    • cramps in your stomach area (abdomen)

  • Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision.

The most common side effects of EBGLYSS include:

  • eye and eyelid inflammation, including redness, swelling, and itching

  • injection site reactions

  • shingles (herpes zoster)

These are not all of the possible side effects of EBGLYSS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

How to take

  • See the detailed “Instructions for Use” that comes with EBGLYSS for information about how to prepare and inject EBGLYSS and how to properly store and throw away (dispose of) used EBGLYSS prefilled pens and prefilled syringes.

  • Use EBGLYSS exactly as prescribed by your healthcare provider.

  • EBGLYSS is given as an injection under the skin (subcutaneous injection).

  • If your healthcare provider decides that you or a caregiver can give the injections of EBGLYSS, you or a caregiver should receive training on the right way to prepare and inject EBGLYSS. Do not try to inject EBGLYSS until you have been shown the right way by your healthcare provider. In children 12 years of age and older, EBGLYSS should be given by a caregiver.

  • If you miss a dose of EBGLYSS, inject the missed dose as soon as possible, then inject your next dose at your regular scheduled time.

Learn more
EBGLYSS is a prescription medicine available as a 250 mg/2 mL injection prefilled pen or prefilled syringe. For more information, call 1-800-545-5979 or go to ebglyss.lilly.com

This summary provides basic information about EBGLYSS but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking to your doctor. Be sure to talk to your doctor or other healthcare provider about EBGLYSS and how to take it. Your doctor is the best person to help you decide if EBGLYSS is right for you.

LK CON BS AD APP

SAFETY SUMMARY

Warnings - Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.

Before using
Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:

  • Have a parasitic (helminth) infection.

  • Are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with EBGLYSS.

  • Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy.

  • Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Possible side effects
EBGLYSS can cause serious side effects, including:

  • Allergic reactions. EBGLYSS can cause allergic reactions that may sometimes be severe. Stop using EBGLYSS and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms:

    • breathing problems or wheezing

    • swelling of the face, lips, mouth, tongue or throat

    • hives

    • itching

    • fainting, dizziness, feeling lightheaded

    • skin rash

    • cramps in your stomach area (abdomen)

  • Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision.

The most common side effects of EBGLYSS include:

  • eye and eyelid inflammation, including redness, swelling, and itching

  • injection site reactions

  • shingles (herpes zoster)

These are not all of the possible side effects of EBGLYSS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

How to take

  • See the detailed “Instructions for Use” that comes with EBGLYSS for information about how to prepare and inject EBGLYSS and how to properly store and throw away (dispose of) used EBGLYSS prefilled pens and prefilled syringes.

  • Use EBGLYSS exactly as prescribed by your healthcare provider.

  • EBGLYSS is given as an injection under the skin (subcutaneous injection).

  • If your healthcare provider decides that you or a caregiver can give the injections of EBGLYSS, you or a caregiver should receive training on the right way to prepare and inject EBGLYSS. Do not try to inject EBGLYSS until you have been shown the right way by your healthcare provider. In children 12 years of age and older, EBGLYSS should be given by a caregiver.

  • If you miss a dose of EBGLYSS, inject the missed dose as soon as possible, then inject your next dose at your regular scheduled time.

Learn more
EBGLYSS is a prescription medicine available as a 250 mg/2 mL injection prefilled pen or prefilled syringe. For more information, call 1-800-545-5979 or go to ebglyss.lilly.com

This summary provides basic information about EBGLYSS but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking to your doctor. Be sure to talk to your doctor or other healthcare provider about EBGLYSS and how to take it. Your doctor is the best person to help you decide if EBGLYSS is right for you.

LK CON BS AD APP

INDICATION

EBGLYSS (EHB-glihs) is an injectable medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe eczema (atopic dermatitis) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. EBGLYSS can be used with or without topical corticosteroids.

It is not known if EBGLYSS is safe and effective in children less than 12 years of age or in children 12 years to less than 18 years of age who weigh less than 88 pounds (40 kg).